ReP USP - Resultado da busca

Artigo de periodico
Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi (2024)
Prates, João Lucas Bruno; Lopes, Juliana Romano ; Chin, Chung Man ; Ferreira, Elizabeth Igne ; Santos, Jean Leandro dos ; Scarim, Cauê Benito
Source: Current Medicinal Chemistry. Unidade: FCF
Subjects: TRYPANOSOMA CRUZI, DOENÇA DE CHAGAS, DESENVOLVIMENTO DE PRODUTOS, PRODUTOS NOVOS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRATES, João Lucas Bruno et al. Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi. Current Medicinal Chemistry, v. 31, n. 16, p. 2285-2308, 2024Tradução . . Disponível em: https://dx.doi.org/10.2174/0109298673254864230921090. Acesso em: 01 nov. 2024.
APA
Prates, J. L. B., Lopes, J. R., Chin, C. M., Ferreira, E. I., Santos, J. L. dos, & Scarim, C. B. (2024). Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi. Current Medicinal Chemistry, 31( 16), 2285-2308. doi:10.2174/0109298673254864230921090
NLM
Prates JLB, Lopes JR, Chin CM, Ferreira EI, Santos JL dos, Scarim CB. Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi [Internet]. Current Medicinal Chemistry. 2024 ; 31( 16): 2285-2308.[citado 2024 nov. 01 ] Available from: https://dx.doi.org/10.2174/0109298673254864230921090
Vancouver
Prates JLB, Lopes JR, Chin CM, Ferreira EI, Santos JL dos, Scarim CB. Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi [Internet]. Current Medicinal Chemistry. 2024 ; 31( 16): 2285-2308.[citado 2024 nov. 01 ] Available from: https://dx.doi.org/10.2174/0109298673254864230921090
Artigo de periodico
Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development (2022)
Pone, Kamdem Boniface ; Dalhatou, Sadou; Paumo, Hugues Kamdem ; Seru, Lebogang Maureen Katata ; Ferreira, Elizabeth Igne
Source: Current Drug Targets. Unidade: FCF
Subjects: TRYPANOSOMA CRUZI, COMPOSTOS HETEROCÍCLICOS, ANTIPROTOZOÁRIOS, DOENÇAS NEGLIGENCIADAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PONE, Kamdem Boniface et al. Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development. Current Drug Targets, v. 23, n. 1, p. 33-59, 2022Tradução . . Disponível em: https://doi.org/10.2174/1389450122666210412125643. Acesso em: 01 nov. 2024.
APA
Pone, K. B., Dalhatou, S., Paumo, H. K., Seru, L. M. K., & Ferreira, E. I. (2022). Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development. Current Drug Targets, 23( 1), 33-59. doi:10.2174/1389450122666210412125643
NLM
Pone KB, Dalhatou S, Paumo HK, Seru LMK, Ferreira EI. Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development [Internet]. Current Drug Targets. 2022 ; 23( 1): 33-59.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2174/1389450122666210412125643
Vancouver
Pone KB, Dalhatou S, Paumo HK, Seru LMK, Ferreira EI. Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development [Internet]. Current Drug Targets. 2022 ; 23( 1): 33-59.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2174/1389450122666210412125643
Artigo de periodico
Anti-Trypanosoma cruzi activity and molecular docking studies of 1Hpyrazolo[ 3, 4-b]pyridine derivatives (2020)
Lima, Camilo Henrique da Silva; Soares, Júlio César de Araujo Vanelis; Ribeiro, Joana Lucius de Sousa; Muri, Estela Maris Freitas; Albuquerque, Sérgio de ; Dias, Luiza Rosaria Sousa
Source: Letters in Drug Design & Discovery. Unidade: FCFRP
Subjects: TRYPANOSOMA CRUZI, TRIPANOSSOMICIDAS, ENSAIO CLÍNICO, CITOTOXICIDADE IMUNOLÓGICA, ANTIPARASITÁRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Camilo Henrique da Silva et al. Anti-Trypanosoma cruzi activity and molecular docking studies of 1Hpyrazolo[ 3, 4-b]pyridine derivatives. Letters in Drug Design & Discovery, v. 17, n. 2, p. 184-191, 2020Tradução . . Disponível em: https://doi.org/10.2174/1570180816666190305141733. Acesso em: 01 nov. 2024.
APA
Lima, C. H. da S., Soares, J. C. de A. V., Ribeiro, J. L. de S., Muri, E. M. F., Albuquerque, S. de, & Dias, L. R. S. (2020). Anti-Trypanosoma cruzi activity and molecular docking studies of 1Hpyrazolo[ 3, 4-b]pyridine derivatives. Letters in Drug Design & Discovery, 17( 2), 184-191. doi:10.2174/1570180816666190305141733
NLM
Lima CH da S, Soares JC de AV, Ribeiro JL de S, Muri EMF, Albuquerque S de, Dias LRS. Anti-Trypanosoma cruzi activity and molecular docking studies of 1Hpyrazolo[ 3, 4-b]pyridine derivatives [Internet]. Letters in Drug Design & Discovery. 2020 ; 17( 2): 184-191.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2174/1570180816666190305141733
Vancouver
Lima CH da S, Soares JC de AV, Ribeiro JL de S, Muri EMF, Albuquerque S de, Dias LRS. Anti-Trypanosoma cruzi activity and molecular docking studies of 1Hpyrazolo[ 3, 4-b]pyridine derivatives [Internet]. Letters in Drug Design & Discovery. 2020 ; 17( 2): 184-191.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2174/1570180816666190305141733
Artigo de periodico
Insights into anti-trypanosomal agents based on synthetic glycoconjugates (2018)
Campo, Vanessa Leiria; Marchiori, Marcelo Fiori; Carvalho, Ivone
Source: Current Topics in Medicinal Chemistry. Unidade: FCFRP
Subjects: TRIPANOSSOMICIDAS, DOENÇAS DE CHAGAS, GLICOCONJUGADOS, TRYPANOSOMA CRUZI, VACINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPO, Vanessa Leiria e MARCHIORI, Marcelo Fiori e CARVALHO, Ivone. Insights into anti-trypanosomal agents based on synthetic glycoconjugates. Current Topics in Medicinal Chemistry, v. 18, n. 5, p. 382-396, 2018Tradução . . Disponível em: https://doi.org/10.2174/1568026618666180509145305. Acesso em: 01 nov. 2024.
APA
Campo, V. L., Marchiori, M. F., & Carvalho, I. (2018). Insights into anti-trypanosomal agents based on synthetic glycoconjugates. Current Topics in Medicinal Chemistry, 18( 5), 382-396. doi:10.2174/1568026618666180509145305
NLM
Campo VL, Marchiori MF, Carvalho I. Insights into anti-trypanosomal agents based on synthetic glycoconjugates [Internet]. Current Topics in Medicinal Chemistry. 2018 ; 18( 5): 382-396.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2174/1568026618666180509145305
Vancouver
Campo VL, Marchiori MF, Carvalho I. Insights into anti-trypanosomal agents based on synthetic glycoconjugates [Internet]. Current Topics in Medicinal Chemistry. 2018 ; 18( 5): 382-396.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2174/1568026618666180509145305
Artigo de periodico
Molecular modeling suggests cruzain specificity for peptide primaquine prodrugs (2010)
Trossini, Gustavo Henrique Goulart ; Chin, Chung Man; Menezes, Carla Maria de Souza; Ferreira, Elizabeth Igne
Source: Letters in Drug Design & Discovery. Unidade: FCF
Subjects: DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI, PROTEINASES, MODELAGEM MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TROSSINI, Gustavo Henrique Goulart et al. Molecular modeling suggests cruzain specificity for peptide primaquine prodrugs. Letters in Drug Design & Discovery, v. 7, n. 7, p. 528-533, 2010Tradução . . Disponível em: https://doi.org/10.2174/157018010791526287. Acesso em: 01 nov. 2024.
APA
Trossini, G. H. G., Chin, C. M., Menezes, C. M. de S., & Ferreira, E. I. (2010). Molecular modeling suggests cruzain specificity for peptide primaquine prodrugs. Letters in Drug Design & Discovery, 7( 7), 528-533. doi:10.2174/157018010791526287
NLM
Trossini GHG, Chin CM, Menezes CM de S, Ferreira EI. Molecular modeling suggests cruzain specificity for peptide primaquine prodrugs [Internet]. Letters in Drug Design & Discovery. 2010 ; 7( 7): 528-533.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2174/157018010791526287
Vancouver
Trossini GHG, Chin CM, Menezes CM de S, Ferreira EI. Molecular modeling suggests cruzain specificity for peptide primaquine prodrugs [Internet]. Letters in Drug Design & Discovery. 2010 ; 7( 7): 528-533.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2174/157018010791526287

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Funding Agencies

Indexado em